CoChat

Multiplex gene editing via CRISPR/Cas9 exhibits desirable muscle hypertrophy without detectable off-target effects in sheep

Wang, Xiaolong, Niu, Yiyuan, Zhou, Jiankui, Yu, Honghao, Kou, Qifang, Lei, Anmin, Zhao, Xiaoe, Yan, Hailong, Cai, Bei, Shen, Qiaoyan, Zhou, Shiwei, Zhu, Haijing, Zhou, Guangxian, Niu, Wenzhi, Hua, Jinlian, Jiang, Yu, Huang, Xingxu, Ma, Baohua, Chen, Yulin · 2016 · Scientific Reports
Cited by 69

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The CRISPR/Cas9 system provides a flexible approach for genome engineering of genetic loci. Here, we successfully achieved precise gene targeting in sheep by co-injecting one-cell-stage embryos with Cas9 mRNA and RNA guides targeting three genes (MSTN, ASIP and BCO2). We carefully examined the sgRNAs:Cas9-mediated targeting effects in injected embryos, somatic tissues, as well as gonads via cloning and sequencing. The targeting efficiencies in these three genes were within the range of 27–33% in generated lambs and that of simultaneously targeting the three genes was 5.6%, which demonstrated that micro-injection of zygotes is an efficient approach for generating gene-modified sheep. Interestingly, we observed that disruption of the MSTN gene resulted in the desired muscle hypertrophy that is characterized by enlarged myofibers, thereby providing the first detailed evidence supporting that gene modifications had occurred at both the genetic and morphological levels. In addition, prescreening for the off-target effect of sgRNAs was performed on fibroblasts before microinjection, to ensure that no detectable off-target mutations from founder animals existed. Our findings suggested that the CRISPR/Cas9 method can be exploited as a powerful tool for livestock improvement by simultaneously targeting multiple genes that are responsible for economically significant traits.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep32271

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic diagram of genetic structures of MSTN, ASIP and BCO2 and their targeting loci of sgRNA:Cas9. sgRNAs targeting sites are highlighted in red, whereas PAM sequences are highlighted in blue. The asterisk indicates the location of the c.196C > T mutation in the BCO2 gene.
Figure 1 Schematic diagram of genetic structures of MSTN, ASIP and BCO2 and their targeting loci of sgRNA:Cas9. sgRNAs targeting sites are highlighted in red, whereas PAM sequences are highlighted in blue. The asterisk indicates the location of the c.196C > T mutation in the BCO2 gene.CC BY · PubMed Central
Figure 2 Detection of the sgRNA:Cas9-mediated off-target cleavage sites in sheep fibroblasts. The PCR products of the potential off-target sites in MSTN, ASIP, and BCO2 sgRNA:Cas9 loci from sheep fibroblasts (a,b). 17 predicted off-target sites that were most homologous to MSTN, ASIP, and BCO2 sgRNAs were named OT1 to OT17. (c,d) Detection of the sgRNA:Cas9- mediated off-target cleavage of MSTN, ASIP, and BCO2 by using the T7EI cleavage assay. All PCR products from (a,b) were subjected to T7EI assay.
Figure 2 Detection of the sgRNA:Cas9-mediated off-target cleavage sites in sheep fibroblasts. The PCR products of the potential off-target sites in MSTN, ASIP, and BCO2 sgRNA:Cas9 loci from sheep fibroblasts (a,b). 17 predicted off-target sites that were most homologous to MSTN, ASIP, and BCO2 sgRNAs were named OT1 to OT17. (c,d) Detection of the sgRNA:Cas9- mediated off-target cleavage of MSTN, ASIP, and BCO2 by using the T7EI cleavage assay. All PCR products from (a,b) were subjected to T7EI assay.CC BY · PubMed Central
Figure 3 Evaluation of sgRNA:Cas9-mediated genetic modifications in lambs. (a) PCR products of the targeted region of the MSTN, ASIP, and BCO2 genes of founder sheep co-microinjected with a mixture of Cas9 mRNA and sgRNAs. D2000 DNA Marker was used as a marker reference. (b) Detection of sgRNA:Cas9-mediated on-target cleavage of the MSTN, ASIP and BCO2 genes by using a T7EI cleavage assay. All PCR products from (a) were subjected to the T7EI cleavage assay. (c) Sequencing results of the modified MSTN, ASIP and BCO2 loci that were detected in the founder animals. Target sequences complementary to sgRNAs of targeted genes are in red text, while the PAM sequences are marked in green. The mutations are marked in blue, dashlines indicates deletions, and lowercase indicates insertions or replacements. Insertions (+), deletions (−), mutations (m) is shown to the right of each allele. The genotypes are shown to the right with the rates of total clones for TA-sequencing.
Figure 3 Evaluation of sgRNA:Cas9-mediated genetic modifications in lambs. (a) PCR products of the targeted region of the MSTN, ASIP, and BCO2 genes of founder sheep co-microinjected with a mixture of Cas9 mRNA and sgRNAs. D2000 DNA Marker was used as a marker reference. (b) Detection of sgRNA:Cas9-mediated on-target cleavage of the MSTN, ASIP and BCO2 genes by using a T7EI cleavage assay. All PCR products from (a) were subjected to the T7EI cleavage assay. (c) Sequencing results of the modified MSTN, ASIP and BCO2 loci that were detected in the founder animals. Target sequences complementary to sgRNAs of targeted genes are in red text, while the PAM sequences are marked in green. The mutations are marked in blue, dashlines indicates deletions, and lowercase indicates insertions or replacements. Insertions (+), deletions (−), mutations (m) is shown to the right of each allele. The genotypes are shown to the right with the rates of total clones for TA-sequencing.CC BY · PubMed Central
Figure 4 Phenotypic analyses of gene-modified sheep targeting MSTN. (a) Birth weight of the MSTN-disrupted and WT lambs. Red dots indicate MSTN-disrupted male founders; red triangles indicate MSTN-disrupted female founders. Blue dots indicate male founders with more than two genes (including MSTN) disrupted, blue triangles indicate female founders with more than two genes (including MSTN) disrupted. Black dots indicate male WT, blue triangles indicate female WT. (b) Body weight changes in MSTN-disrupted and WT sheep from D0 to D240. *p < 0.05, **p < 0.01, student’s t-test. (c) The average daily gain (ADG) of MSTN-disrupted and WT sheep from D0 to D240. (d) H&E staining shows the morphology of myofibers in the muscles of WT and MSTN-disrupted (MUT) (#29) sheep. (e) TEM analyses of muscle tissues of a mutant (#29) and WT sheep at D120. Scale bars: left = 2 μm. (f) The diameter of myofibers for a mutant (#29) and WT sheep. (g) Western blotting analysis using anti-MSTN and anti-GAPDH (loading control) antibodies in a MSTN-disrupted sheep (MUT(#29)) and WT (#504).
Figure 4 Phenotypic analyses of gene-modified sheep targeting MSTN. (a) Birth weight of the MSTN-disrupted and WT lambs. Red dots indicate MSTN-disrupted male founders; red triangles indicate MSTN-disrupted female founders. Blue dots indicate male founders with more than two genes (including MSTN) disrupted, blue triangles indicate female founders with more than two genes (including MSTN) disrupted. Black dots indicate male WT, blue triangles indicate female WT. (b) Body weight changes in MSTN-disrupted and WT sheep from D0 to D240. *p < 0.05, **p < 0.01, student’s t-test. (c) The average daily gain (ADG) of MSTN-disrupted and WT sheep from D0 to D240. (d) H&E staining shows the morphology of myofibers in the muscles of WT and MSTN-disrupted (MUT) (#29) sheep. (e) TEM analyses of muscle tissues of a mutant (#29) and WT sheep at D120. Scale bars: left = 2 μm. (f) The diameter of myofibers for a mutant (#29) and WT sheep. (g) Western blotting analysis using anti-MSTN and anti-GAPDH (loading control) antibodies in a MSTN-disrupted sheep (MUT(#29)) and WT (#504).CC BY · PubMed Central
Figure 5 Detection of germline transmission in founder animals. (a) Immunostaining analysis of biopsied testis of the founder (#28) at 120-day-old, confirmed by germ cell specific marker VASA. Germ cells from the testis were stained with an anti-VASA antibody (green) and Hoechst 33342 (blue). VASA positive cells are germ cells. VASA negative cells were used as negative control. Scale bar = 200 μm. (b–e) PCR products of the targeted loci and detection of sgRNA:Cas9-mediated on-target cleavage in germ cells (GCs) and blood cells (BCs) from founders (#28, #33, and #37).
Figure 5 Detection of germline transmission in founder animals. (a) Immunostaining analysis of biopsied testis of the founder (#28) at 120-day-old, confirmed by germ cell specific marker VASA. Germ cells from the testis were stained with an anti-VASA antibody (green) and Hoechst 33342 (blue). VASA positive cells are germ cells. VASA negative cells were used as negative control. Scale bar = 200 μm. (b–e) PCR products of the targeted loci and detection of sgRNA:Cas9-mediated on-target cleavage in germ cells (GCs) and blood cells (BCs) from founders (#28, #33, and #37).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 32

  1. Yang H. L.. Bone healing response to a synthetic calcium sulfate/β-tricalcium phosphate graft material in a sheep vertebral body defect model. J. Biomed. Mater. Res. 100B, 1911– 1921 (2012). PMC3531612 22847979 · doi:10.1002/jbm.b.32758
  2. Malhotra A., Pelletier M. H., Yu Y., Christou C. & Walsh W. R. A Sheep Model for Cancellous Bone Healing. Frontiers in Surgery 1, 10.3389 (2014). PMC4286987 25593961 · DOI
  3. Abbasi K.. Perivascular Nitric Oxide Delivery to Saphenous Vein Grafts Prevents Graft Stenosis after Coronary Artery Bypass Grafting: A Novel Sheep Model. Cardiology 118, 8– 15 (2011). 21389715 · DOI
  4. Fransolet M.. Strategies for Using the Sheep Ovarian Cortex as a Model in Reproductive Medicine. PLoS One 9, e91073 (2014). 24614306 PMC3948732 · doi:10.1371/journal.pone.0091073
  5. Cornetta K.. Transgenic sheep generated by lentiviral vectors: safety and integration analysis of surrogates and their offspring. Transgenic Res 22, 737– 745 (2012). 23180364 PMC3606283 · DOI
  6. Hu S.. Knockdown of Myostatin Expression by RNAi Enhances Muscle Growth in Transgenic Sheep. PLOS One 8, e58521 (2013). 23526994 PMC3603981 · DOI
  7. Zhang C.. Targeted disruption of the sheep MSTN gene by engineered zinc-finger nucleases. Mol Biol Rep 41, 209– 215 (2013). 24197697 · DOI
  8. Proudfoot C.. Genome edited sheep and cattle. Transgenic Res 24, 147– 153 (2014). 25204701 PMC4274373 · DOI · Paper page
  9. Mali P.. RNA-Guided Human Genome Engineering via Cas9. Science 339, 823– 826 (2013). 23287722 PMC3712628 · DOI · Paper page
  10. Shan Q.. Targeted genome modification of crop plants using a CRISPR-Cas system. Nat Biotech 31, 686– 688 (2013). 23929338 · DOI · Paper page
  11. Hai T., Teng F., Guo R., Li W. & Zhou Q. One-step generation of knockout pigs by zygote injection of CRISPR/Cas system. Cell Res 24, 372– 375 (2014). 24481528 PMC3945887 · DOI · Paper page
  12. Ni W.. Efficient Gene Knockout in Goats Using CRISPR/Cas9 System. PLOS One 9, e106718 (2014). 25188313 PMC4154755 · DOI · Paper page
  13. Wang X.. Generation of gene-modified goats targeting MSTN and FGF5 via zygote injection of CRISPR/Cas9 system. Sci Rep 5, 10.103 (2015). PMC4564737 26354037 · DOI · Paper page
  14. Zou Q.. Generation of gene-target dogs using CRISPR/Cas9 system. J Mol Cell Biol 7, 580– 583 (2015). 26459633 · DOI · Paper page
  15. Crispo M.. Efficient Generation of Myostatin Knock-Out Sheep Using CRISPR/Cas9 Technology and Microinjection into Zygotes. PLoS One 10, e0136690 (2015). 26305800 PMC4549068 · DOI · Paper page
  16. Boman I. A., Klemetsdal G., Blichfeldt T., Nafstad O. & Våge D. I. A frameshift mutation in the coding region of the myostatin gene (MSTN) affects carcass conformation and fatness in Norwegian White Sheep (Ovis aries). Anim Genet 40, 418– 422 (2009). 19392824 · DOI · Paper page
  17. Boman I. A., Klemetsdal G., Nafstad O., Blichfeldt T. & Våge D. I. Impact of two myostatin (MSTN) mutations on weight gain and lamb carcass classification in Norwegian White Sheep (Ovis aries). Genet Sel Evol 42, 4, 10.1186 (2010). 20113462 PMC2841581 · DOI
  18. Norris B. J. & Whan V. A. A gene duplication affecting expression of the ovine ASIP gene is responsible for white and black sheep. Genome Res. 18, 1282– 1293 (2008). 18493018 PMC2493430 · DOI · Paper page
  19. Fontanesi L.. Characterization of the rabbit agouti signaling protein (ASIP) gene: Transcripts and phylogenetic analyses and identification of the causative mutation of the nonagouti black coat colour. Genomics 95, 166– 175 (2010). 20004240 · DOI
  20. Fontanesi L., Dall’Olio S., Beretti F., Portolano B. & Russo V. Coat colours in the Massese sheep breed are associated with mutations in the agouti signalling protein (ASIP) and melanocortin 1 receptor (MC1R) genes. Animal 5, 8– 17 (2011). 22440696 · DOI
  21. Royo L. J.. Differences in the expression of the ASIP gene are involved in the recessive black coat colour pattern in sheep: evidence from the rare Xalda sheep breed. Anim Genet 39, 290– 293 (2008). 18384465 · DOI
  22. Våge D. I. & Boman I. A. A nonsense mutation in the beta-carotene oxygenase 2 (BCO2) gene is tightly associated with accumulation of carotenoids in adipose tissue in sheep (Ovis aries). BMC Genet 11, 10, 10.1186 (2010). 20122251 PMC2828402 · DOI · Paper page
  23. Vigl K., Monshi B., Vujic I. & Rappersberger K. Pyoderma gangrenosum-like necrotizing panniculitis associated with alpha-1 antitrypsin deficiency: a lethal course. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 13, 1180– 1184 (2015). 26513086
  24. Shen B.. Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res. 23, 720– 723 (2013). 23545779 PMC3641603 · DOI · Paper page
  25. Xie K., Zhang J. & Yang Y. Genome-wide prediction of highly specific guide RNA spacers for CRISPR-Cas9-mediated genome editing in model plants and major crops. Mol Plant 7, 923– 926 (2014). 24482433 · DOI · Paper page
  26. Jao L.-E., Wente S. R. & Chen W. Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc. Natl. Acad. Sci. USA 110, 13904– 13909 (2013). 23918387 PMC3752207 · DOI · Paper page
  27. Niemann H. & Kues W. A. Transgenic farm animals: an update. Reprod. Fertil. Dev. 19, 762– 770 (2007). 17714630 · DOI
  28. Blash S., Schofield M., Echelard Y. & Gavin W. Update on the first cloned goats. Nat Biotech 30, 229– 230 (2012). 22398615 · doi:10.1038/nbt.2140
  29. Chen Y.. Germline acquisition of Cas9/RNA-mediated gene modifications in monkeys. Cell Res 25, 262– 265 (2015). 25533168 PMC4650569 · DOI
  30. Hruscha A.. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish. Development. 140, 4982– 4987 (2013). 24257628 · DOI · Paper page
  31. Haidet A. M.. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc. Natl. Acad. Sci. USA 105, 4318– 4322 (2008). 18334646 PMC2393740 · DOI · Paper page
  32. Ge S.-N.. Differential expression of VGLUT1 or VGLUT2 in the trigeminothalamic or trigeminocerebellar projection neurons in the rat. Brain Struct Funct 219, 211– 229 (2014). 23380804 · DOI

Cited by

Metadata

Authors
Wang, X., Niu, Y., Zhou, J., Yu, H., Kou, Q., Lei, A., Zhao, X., Yan, H., Cai, B., Shen, Q., Zhou, S., Zhu, H., Zhou, G., Niu, W., Hua, J., Jiang, Y., Huang, X., Ma, B., & Chen, Y.
Venue
Scientific Reports
Published
2016-08-26
Volume
6
Issue
1
ISSN
2045-2322
Cited by
69
References
7
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.